2025. Anlotinib Monotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter Case-Series Analysis: Anlotinib in NPC. Radiology and Oncology. 59, 4 (Dec. 2025), 617–623.